top of page

Antibiotics

Placeholder Image

Bactigent Capsule

Indication: For treatment of infections of ears, nose, and throat; due to Streptocci, Pneucocci, non-penicillinase producing Staphylococci and H-influenza, genito-urinary tract infections due to E.coli, Proteus Mirabilis and Streptococcus faecalis; gonorrhea, actinomycosis, infections of lower respiratory tract; bronchitis, gastroenteritis (effective against disorders, Cyme disease, endocarditisi) FDA Reg. No.: DRP-316-03

Placeholder Image

Bactigent Suspension

Indication: For the treatment of infections caused by susceptible strains of Gram positive and Gram negative organisms such as respiratory, gastrointestinal and genitourinary tract, skin and soft tissues infections. i) FDA Reg. No.: DRP-1425-06

Nerfalex 100mg/mL Granules for Suspension (Oral Drops) 15mL

Indication: For treatment of respiratory tract infections, otitis media, skin and skin structure infections, bone infections and genitourinary tract infections. FDA REG. NO.: DR-XY17890

Nerfalex 250mg/5mL Granules for Suspension 60mL

Indication: For treatment of respiratory tract infections, otitis media, skin and skin structure infections, bone infections and genitourinary tract infections. FDA REG. NO.: DR-XY17869

Nerfalex 500mg Capsule

Indication: For treatment of respiratory tract infections, otitis media, skin and skin structure infections, bone infections and genitourinary tract infections. FDA REG. NO.: DR-XY20480

Profilox Tablet

Indication:
For treatment of Respiratory Tract infection, Urinary Tract infection, ENT Infections, Gonorrhea, Skin and Soft Tissue infections, Gastrointestinal tract infections, Intra-abdominal infections, Gynaecological infections, Bone-joint infections and Severe Systemic infections.
FDA Reg. No.: DRP-276-02

Rezafil IV 750mg Powder for Injection (IM/IV)

Indication: Used in the treatment of susceptible infections such as bone and joint infections, bronchitis (lower respiratory infection), gonorrhea, meningitis, otitis media, peritonitis, pharyngitis, sinusitis, skin infections and urinary tract infections.
FDA REG. NO.: DRP-3995-17

bottom of page